biomarkers ALK Expression ALK Fusion ATIC-ALK Fusion CLTC-ALK Fusion inv(2)(p23q35) MSN-ALK Fusion MYH9-ALK Fusion NPM1-ALK Fusion RNF213-ALK Fusion t(1;2)(q25;p23) t(2;17)(p23;q23) t(2;17)(p23;q25) t(2;19)(p23;p13.1) t(2;22)(p23;q11.2) t(2;3)(p23;q12.2) t(2;5)(p23;q35) TFG-ALK Fusion TPM3-ALK Fusion TPM4-ALK Fusion t(X;2)(q11-12;p23)
alectinib ALK Fusion Non-Small Cell Lung Carcinoma Advanced, +1 more state Subsequent line alectinib targeted therapy
alectinib ALK Fusion Non-Small Cell Lung Carcinoma Advanced, +1 more state First line alectinib targeted therapy
T-Cell Lymphomas (NCCN Guidelines)
[2.2022]
Cancer Search
